Early circulating tumor (ct)DNA dynamics and efficacy of lorlatinib in patients (pts) with advanced ALK-positive non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Shaw, A. T.; Martini, J. F.; Besse, B.; Bauer, T. M.; Lin, C. C.; Soo, R. A.; Riely, G. J.; Ou, S. H. I.; Abbattista, A.; Toffalorio, F.; Thurm, H. C.; Satouchi, M.; Camidge, D. R.; Kao, S. C. H.; Chiari, R.; Gadgeel, S. M.; Felip, E.; Solomon, B. J.
Abstract Title: Early circulating tumor (ct)DNA dynamics and efficacy of lorlatinib in patients (pts) with advanced ALK-positive non-small cell lung cancer (NSCLC)
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 481s
Language: English
ACCESSION: WOS:000487345806463
PROVIDER: wos
DOI: 10.1200/JCO.2019.37.15_suppl.9019
Notes: Meeting Abstract: 9019 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely